INTRODUCTION: In our constant search for the latest innovations in non‐invasive health and medical advancements, HealthTech Reporter met with DR. DANIEL BEILIN of Alfa Thermodiagnostics, the developer of the ALFASIGHT 9000.
In August of 2024, HealthTech Reporter conducted a private interview with Dr. Daniel Beilin (CTO & Founder) about establishing the science of Regulation Thermography and his ALFA System.
The AlfaSight 9000™ (also known as the ALFA‐Scan System) is a robust, easy‐to use, and reproducible measurement system that utilizes streamlined infrared technology, artificial intelligence (AI) ‐ and years of world‐corroborated, accumulated data. It’s a whole‐body, early‐detection system that views a patient’s overall health while finding hidden issues and causes for many disease including pre‐disease contributing factors.
According to the manufacturer, this adjunct diagnostic device may detect the following Organ Dysfunctions:
‐ Diabetes and Pre‐Diabetes (Pancreas) ‐ Breast (Breast Health, DCIS and Cystic Changes) ‐ Vascular Brain and Headache Origins ‐ Liver Disorders and Disease ‐ Endocrine Function (Pituitary/Thyroid/Ovary) ‐ Cardiac Function (Efficiency, Electrophysiology) | ‐ Early or Hidden Dental Infections ‐ Structural Integrity (Neuromuscular) ‐ Pulmonary Function ‐ Viral and Bacterial Disease Monitoring ‐ Kidney Dysfunction ‐ Lymphatic Monitoring |
Dr. Daniel Beilin is an American specialist in alternative medicine for over 35 years. He has a neurophysiology, gastroenterology, and herbal sciences background. His first research at the age of 16 included his own laboratory at the UCLA Brain Research Institute and is now internationally recognized for his contributions to detection of the causes of cancer and immune dysfunction with cutting‐edge precision‐based European diagnostic tools
PHILOSOPHIES: I was six and a half years in academic medical
research when I decided that conventional medicine
as it is practiced relies on quick recipe formulas that all too‐often
disregard the individual case and differences of the constitutional strengths
and weaknesses of patients. Whereas (truth is), every individual is different;
the same pneumonia patient can have a different etiology and a different organ
involvement that helps to make the person vulnerable to not only pulmonary disease, but lays a
susceptibility to other diseases including cancers or autoimmune disorders.
I wanted to explore the terrain, which
means that our own physiological functions affected by the autonomic nervous system, our metabolism, environmental
toxic exposures, our diet‐‐ all of these factors are usually ignored
by conventional medicine. When someone walks in a clinic with
a particular disease, physicians all too often target the end
stage symptom and rarely identify CAUSE, thereby
never addressing long term prevention. They can save lives as surgeons can definitely do a good job of that, but then what? In
the search for a preventive world, there must be an understanding of how to see
things that are originally invisible, diseases that are developing, ‐and not yet causing tissue damage or advancing pathology, as would be seeable in a blood test.
Alfa’s technology
vaguely overlaps acupuncture, Ayurvedic and Chinese medicine,
however traditional medicine needs more objective and reproducible diagnostics
that can finally be gained by the sensitivity and specificity of Regulation
Thermometry. It's more in line with neurology. The doctors that can
immediately understand what we're doing by our device are nuclear medicine
physicians and cardiologists... because what we're really doing is a process of
challenging the body and examining
the responses to the challenge. We do this simply by subjecting the patient to the cooler
air of a normal room, before and after clothing removal. By this dynamic temperature
analysis, we can understand health, like opening up a new visual method of
invisible causes that explain many disease processes from their beginnings. We are finally
able to see the resilience characteristics expressed through each organ
system by simple stress-analysis. From here, we take a 'before and after' exposure
measurements, then we're able
to define where in the body are the non‐ideal atypical responses, then
corroborate with directed, specific laboratory tests or imaging diagnostics.
MY HISTORICAL PATH OF THE ALFASIGHT 9000:
I started
this path by
visiting clinics
and laboratories in Germany
in 1979. Over the next 40 years, I attended in
different integrative medicine clinics and hospitals in Europe . As you may know, Germany has
always combined conventional medicine with
alternative methods such as homeopathic medicine, herbal medicine and
nutritional medicine. The Europeans are the most open‐minded
alongside being science-based, and of course, very ‘logical’ in the way
they think (over 50% of physicians in Germany utilize some form of
unconventional medicine such as acupuncture, nutrition or physical
therapeutic methods.
There was a Dr. Schwamm who invented this method of neurologically‐based regulation analysis. I explored his work through his students (since he had died by the time I got there). One of them was a Dr. Reimar Banis who was an internist who partnered with a gynecologist, told me about this great diagnostic tool. They had discovered hidden factors in their scans that proved to lead to breast and cervical cancers.
To clarify, I did not invent the technology, but I led a
team and improved the hardware (and software) it vastly to be more stable and
accurate. We identified patterns of disease-complexes by
repeated testing of hypothetical variants which led
to establishing formulas or algorithms (pattern recognition). The values that
we now acquire are more highly calibrated to detect disturbances in signaling
from physiological systems and make them even more recognizable. Banis
came to me and said, "I know the guy that is manufacturing
the devices, so why don't you see if you can get it through the FDA, and then you could distribute them and then educate doctors." So that's exactly
what I did.
I brought
this original device to FDA, cleared
it with the Department of Radiological Devices
and distributed them to over 120 clinics in North
America . I then improved the device and got the second one cleared
with FDA. We began a new introduction to the device in leading integrative
medicine conferences, as it clearly gives a new vision to the causes of many
disorders and syndromes. We were then
endorsed by physicians who are leaders in the field of complementary medicine.
MORE DETAILS ON WHAT IT DOES
This method of
measuring skin temperatures before and after a stress by temperature change,
isn’t trying to look INSIDE the body like an X-Ray or MRI, but instead it is taking the skin's temperature within organ‐’reflection’ zones, -as the skin is controlled by the sympathetic nerves that control capillaries to open and close, letting heat out or keeping heat in. In fact, we're using the sympathetic nervous system by way of connections
through the spinal REFLEX ARC, connecting with the internal organs
carrying projected information from specific organ systems as well as tissues such as
breasts, lymph and through pattern-recognition, identifies many more syndromes
as well as neurological problems.
THE PATIENT EXPERIENCE
It's a single 20‐minute test. It involves taking the first measurement from the head down to just below the waist, and then removing clothes to the underwear, so that the patient then becomes exposed to the cooler room-air for 10 minutes. This initiates a fight or flight reaction whereby the blood shunts to your core and to your head. The response is quantified according to known patterns that have been corroborated with laboratory tests and imaging over the last 45 years (Europe originally).
By looking at the responses, before and after cooling, in approximately a hundred points, we're able to obtain information about organ systems that may be abnormally functioning those that are in their infancy stage up to their actual disease state. This opens up a whole new window for true, preventive care.
Five years ago,
I presented at Beth Deaconess Hospital
in Boston
(Harvard) to 10 radiologists. One of
them was the lead expert who leads all breast cancer radiological
research, trying to use computer assisted
diagnostics (CAD) and applying artificial intelligence to
mammograms. She told me at the time that their computer assisted diagnosis was
a near‐ complete failure and that the radiologist's eyes are still the most
accurate assessment tool.
This uses up a
lot of hours and manpower and very highly trained, trained people. She liked the
Alfa system because it, as she said, “digitizes, making results objective”,
and “it looks like you have algorithms that may depict developing breast
cancers, which is what we are looking for in our research."
We planned a study on breast assessment in two categories. Ones that are not yet known, whether they're producing a neoplasm (cancer tumor) yet, and known breast cancers that have been treated, in order to better establish categories of patterns depicting recurrence probability.
Within this time, the FDA cleared our 510k and declared our device, the AlfaSight 9000 system as an ADJUNCT diagnostic system. This means that it doesn't tell you that you have cancer; if you have hepatitis (per‐se), but instead, it tells you that "you better do some imaging in this area‐‐ or perhaps you ought to go out for a blood test here because we have the pattern of, say, autoimmune thyroid like Hashimoto's or Graves disease" but need to confirm in specific, cost‐effective ways.
This kind of information gathered by this dynamic, functional physiological analysis approach assists doctors in making better decisions on what to test for and ways to individualize protocol treatment strategies. The Alfa system has a very high specificity for about 35 conditions. The test takes 20 minutes and certified technicians can be taught
how to operate it in an hour‐ which includes
generating a report based on all the data that's accumulated for proper
interpretation and strategy-planning.
To date, we have
180 devices in 14 countries right now. Planned is a new project with the now-largest
hospital in Asia (AIMS
Hospital , just outside Delhi with the lead
physician, Dr. Prem Nair. We are advancing into projects with our device that may
lead to a crucial step: functional physiological resilience
analysis.
Patients improve
faster and more completely if they are systemically resilient, now there is a
method to measure that resilience. My
hope and clear goal is to maximize that possibility with this reproducible data-driven
comprehensive measurement tool.
Contact: https://alfathermo.com
info@alfathermo.com
drbeilin@alfathermo.com
tel: (831) 708‐2212
No comments:
Post a Comment